Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (1) Dechend, Ralf Priv. Doz. (25) Herse, Florian PD Dr. (7) Infante Duarte, Carmen (1) Janke, Jürgen Dr. (2) Luft, Friedrich Prof. Dr. (20) Marko, Lajos Dr. (2) Millward, Jason Dr. (1) Niendorf, Thoralf Prof. Dr. (20) Paul, Friedemann Prof. Dr. med. (2) Pilz, Bernhard Dr. (1) Qadri, Fatimunnisa Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schulz-Menger, Jeanette Prof. Dr. (6) Waiczies, Helmar Dr. (2) Waiczies, Sonia PD Dr. (3) Wallukat, Gerd Dr. (5) Wellner, Maren Dr. (1) Wenzel, Katrin Dr. (1) Winter, Lukas Dr. (3) (-) Müller, Dominik Prof. Dr. (27) 1995 (1) 1997 (1) 1998 (3) 1999 (3) 2000 (6) (-) 2001 (12) 2002 (8) 2003 (5) (-) 2004 (6) 2005 (10) 2006 (4) 2007 (14) 2008 (18) 2009 (15) 2010 (15) 2011 (13) (-) 2012 (13) 2013 (22) 2014 (14) 2015 (20) 2016 (18) 2017 (20) 2018 (17) 2019 (22) 2020 (29) 2021 (40) 2022 (10) 2023 (11) 2024 (2) AG Müller/Dechend (ECRC) (27) Cardiac MRI (1) (-) Experimental Ultrahigh-Field MR (5) Hypertension-caused End-Organ Damage (27) (-) Hypertension-Mediated End-Organ Damage (27) Innate Immunity & Neuroinflammation (1) Magnetic Resonance (5) Molecular Biology of Peptide Hormones (1) 31 Results: Active Filter: Müller, Dominik Prof. Dr.Experimental Ultrahigh-Field MRHypertension-Mediated End-Organ Damage200120042012 Sort: Result score Newest to oldest Oldest to newest June 08, 2004 / Circulation Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells I. Mazak A. Fiebeler D.N. Muller J.K. Park E. Shagdarsuren C. Lindschau R. Dechend C. Viedt B. Pilz H. Haller F.C. Luft December 01, 2004 / Semin Nephrol AT1 receptor agonistic antibodies, hypertension, and preeclampsia R. Dechend D.N. Mueller G. Wallukat V. Homuth M. Krause J. Dudenhausen F.C. Luft January 01, 2004 / Am J Pathol A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury D.N. Muller J. Theuer E. Shagdarsuren E. Kaergel H. Honeck J.K. Park M. Markovic E. Barbosa-Sicard R. Dechend M. Wellner T. Kirsch A. Fiebeler M. Rothe H. Haller F.C. Luft W.H. Schunck January 01, 2004 / Am J Kidney Dis Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases A. Fiebeler J.K. Park D.N. Muller C. Lindschau M. Mengel S. Merkel B. Banas F.C. Luft H. Haller May 01, 2004 / J Hypertens Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice V. Gross M. Obst E. Kiss J. Janke I. Mazak E. Shagdarsuren D.N. Mueller T.H. Langenickel H.J. Groene F.C. Luft June 01, 2004 / Kidney Int Nitric oxide synthase expression in AT receptor-deficient mice after DOCA-salt M. Obst V. Gross A. Bonartsev J. Janke D.N. Mueller J.K. Park E. Kaergel F.C. Luft January 01, 2001 / J Mol Med Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research M. Bader J. Peters O. Baltatu D.N. Mueller F.C. Luft D. Ganten January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
June 08, 2004 / Circulation Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells I. Mazak A. Fiebeler D.N. Muller J.K. Park E. Shagdarsuren C. Lindschau R. Dechend C. Viedt B. Pilz H. Haller F.C. Luft
December 01, 2004 / Semin Nephrol AT1 receptor agonistic antibodies, hypertension, and preeclampsia R. Dechend D.N. Mueller G. Wallukat V. Homuth M. Krause J. Dudenhausen F.C. Luft
January 01, 2004 / Am J Pathol A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury D.N. Muller J. Theuer E. Shagdarsuren E. Kaergel H. Honeck J.K. Park M. Markovic E. Barbosa-Sicard R. Dechend M. Wellner T. Kirsch A. Fiebeler M. Rothe H. Haller F.C. Luft W.H. Schunck
January 01, 2004 / Am J Kidney Dis Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases A. Fiebeler J.K. Park D.N. Muller C. Lindschau M. Mengel S. Merkel B. Banas F.C. Luft H. Haller
May 01, 2004 / J Hypertens Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice V. Gross M. Obst E. Kiss J. Janke I. Mazak E. Shagdarsuren D.N. Mueller T.H. Langenickel H.J. Groene F.C. Luft
June 01, 2004 / Kidney Int Nitric oxide synthase expression in AT receptor-deficient mice after DOCA-salt M. Obst V. Gross A. Bonartsev J. Janke D.N. Mueller J.K. Park E. Kaergel F.C. Luft
January 01, 2001 / J Mol Med Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research M. Bader J. Peters O. Baltatu D.N. Mueller F.C. Luft D. Ganten
January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft
January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft
January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller